Healthcare - Biotechnology - NASDAQ - US
$ 34.45
-1.71 %
$ 9.84 B
Market Cap
22.23
P/E
INCOME STATEMENT
1.83 B
REVENUE
171 M
OPERATING INCOME
208 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Exelixis, Inc.
| Revenue | 1.83 B |
| Cost Of Revenue | 72.5 M |
| Gross Profit | 1.76 B |
| Operating Expenses | 1.59 B |
| Operating Income | 171 M |
| Other Expenses | -36.9 M |
| Net Income | 208 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Jan-2021 | Jan-2020 | Dec-2018 | Dec-2017 | Dec-2016 | Jan-2016 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Jan-2010 | Jan-2009 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 1 830.2 | 1 611.1 | 1 435.0 | 987.5 | 967.8 | 853.8 | 452.5 | 191.5 | 37.2 | 25.1 | 31.3 | 47.5 | 289.6 | 185.0 | 151.8 | 117.9 | 113.5 | 98.7 | 76.0 | 52.9 | 51.5 | 44.3 | 41.0 | 24.8 | 10.5 | 2.3 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 72.5 | 57.9 | 52.9 | 36.3 | 33.1 | 26.3 | 15.1 | 6.6 | 3.9 | 2.0 | 1.1 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.8 | 1.1 | 0.8 | 0 | 0 | 0 | (18.6) | (5.7) | 0 |
| Gross Profit | 1 757.7 | 1 553.2 | 1 382.1 | 951.3 | 934.7 | 827.5 | 437.4 | 184.9 | 33.3 | 23.1 | 30.2 | 47.5 | 289.6 | 185.0 | 151.8 | 117.9 | 113.3 | 97.8 | 74.9 | 52.1 | 51.5 | 44.3 | 41.0 | 43.4 | 16.2 | 2.3 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 1 586.8 | 1 351.7 | 1 095.4 | 841.2 | 565.2 | 388.6 | 271.5 | 212.1 | 153.7 | 239.9 | 229.7 | 160.7 | 190.0 | 243.7 | 273.7 | 298.9 | 307.5 | 225.4 | 170.0 | 159.4 | 146.9 | 131.4 | 109.6 | 86.2 | 35.0 | 17.6 |
| Selling, General and Administrative Expenses | 542.7 | 459.9 | 401.7 | 293.4 | 228.2 | 206.4 | 159.4 | 116.1 | 57.3 | 50.8 | 51.0 | 31.8 | 33.1 | 33.0 | 39.0 | 36.9 | 44.9 | 39.1 | 27.7 | 20.9 | 18.6 | 18.8 | 19.2 | 18.9 | 7.6 | 5.5 |
| Research and Development Expenses | 1 044.1 | 891.8 | 693.7 | 547.9 | 337.0 | 182.3 | 112.2 | 96.0 | 96.4 | 189.1 | 178.8 | 128.9 | 156.8 | 210.7 | 234.7 | 257.4 | 225.4 | 185.5 | 141.1 | 137.7 | 127.6 | 112.0 | 82.7 | 48.5 | 21.7 | 12.1 |
| Operating Income | 170.9 | 201.5 | 286.7 | 110.1 | 369.5 | 438.9 | 165.9 | (28.1) | (121.4) | (224.5) | (200.7) | (122.4) | 89.5 | (91.4) | (121.9) | (179.3) | (157.0) | (126.8) | (94.0) | (135.2) | (96.3) | (87.8) | (75.3) | (42.9) | (18.8) | (15.3) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 | 8.7 | 33.1 | 48.7 | 48.6 | 45.3 | 27.1 | 16.3 | 9.3 | 12.7 | 6.8 | (4.0) | (5.0) | (6.2) | (5.4) | (3.7) | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 86.6 | 32.9 | 7.5 | 20.8 | 28.6 | 13.2 | (7.3) | (42.1) | (40.3) | (44.3) | (44.1) | (25.1) | (12.5) | (1.0) | (18.9) | 3.7 | 46.0 | 25.3 | (0.8) | (2.0) | 1.1 | 3.3 | (9.4) | (38.1) | 0 | (0.4) |
| Pre-Tax Income | 257.5 | 234.4 | 294.2 | 130.8 | 398.1 | 452.1 | 158.6 | (70.2) | (169.7) | (268.7) | (244.9) | (147.5) | 77.0 | (92.4) | (140.8) | (162.9) | (86.4) | (101.5) | (94.8) | (137.2) | (95.1) | (84.5) | (84.7) | (81.0) | 0 | (15.7) |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 49.8 | 52.1 | 63.1 | 19.1 | 77.1 | (238.0) | 4.3 | 32.1 | 55 K | (0.2) | 96 K | 0.1 | 1.3 | 72 K | (1.3) | (18.1) | (107.6) | 0 | (9.6) | 30.7 | (0.3) | 0.3 | 2.5 | 32.4 | 100 K | 0 |
| Net Income | 207.8 | 182.3 | 231.1 | 111.8 | 321.0 | 690.1 | 154.2 | (70.2) | (169.7) | (268.5) | (244.8) | (147.6) | 75.7 | (92.3) | (135.2) | (162.9) | (86.4) | (101.5) | (84.4) | (137.2) | (94.8) | (86.1) | (71.2) | (75.3) | (18.7) | (15.7) |
| EPS | 0.65 | 0.57 | 0.73 | 0.36 | 1.06 | 2.32 | 0.52 | 0.28 | 0.81 | 1.38 | 1.33 | 0.92 | 0.6 | 0.85 | 1.26 | 1.54 | 0.87 | 1.17 | 1.07 | 1.89 | 1.45 | 1.52 | 1.53 | 2.43 | 4.6 | 7.88 |